DSpace at RU >

Browsing by Author Lugt, J. van der

Full Text	Issue Date	Title	Author(s)
	2011	Thai HIV-1-infected women do not require a dose increase of lopinavir/ritonavir during the third trimester of pregnancy.	Ramautarsing, R.A.; Lugt, J. van der; Gorowara, M.; Kerr, S.J.; Burger, D.M., et al
	2009	Pharmacokinetics and 48 week efficacy of low-dose lopinavir/ritonavir in HIV-infected children.	Puthanakit, T.; Lugt, J. van der; Bunupuradah, T.; Ananworanich, J.; Gorowara, M., et al
	2009	The pharmacokinetics, safety and efficacy of boosted saquinavir tablets in HIV type-1-infected pregnant women.	Lugt, J. van der; Colbers, A.; Molto, J.; Hawkins, D.; Ende, M. van der, et al
	2009	A low dose of ritonavir-boosted atazanavir provides adequate pharmacokinetic parameters in HIV-1-infected Thai adults.	Avihingsanon, A.; Lugt, J. van der; Kerr, S.J.; Gorowara, M.; Chanmano, S., et al
	2009	Reducing the boosting dose of ritonavir does not affect saquinavir plasma concentrations in HIV-1-infected individuals.	Lugt, J. van der; Gorowara, M.; Avihingsanon, A.; Burger, D.M.; Ananworanich, J., et al
	2009	Plasma concentrations of generic lopinavir/ritonavir in HIV type-1-infected individuals.	Lugt, J. van der; Lange, J.; Avihingsanon, A.; Ananworanich, J.; Sealoo, S., et al
	2009	Safety and efficacy of a double-boosted protease inhibitor combination, saquinavir and lopinavir/ritonavir, in pretreated children at 96 weeks.	Bunupuradah, T.; Lugt, J. van der; Kosalaraksa, P.; Engchanil, C.; Boonrak, P., et al
	2008	Pharmacokinetics and short-term efficacy of a double-boosted protease inhibitor regimen in treatment-naive HIV-1-infected adults.	Lugt, J. van der; Autar, R.S.; Ubolyam, S.; Garcia, E.F.; Sankote, J., et al
	2008	Clinical pharmacology of HIV protease inhibitors in pregnancy	Lugt, J. van der; Colbers, A.; Burger, D.M.